Alternative Test Methods: Validation and Regulatory Status
- Acute Aquatic Toxicity
- Acute Mammalian Oral Toxicity
- Acute Mammalian Inhalation Toxicity
- Acute Mammalian Skin Toxicity
- Biologics (non-vaccine)
- Carcinogenicity
- Chronic/Repeated Dose Toxicity
| Conventional test method | Alternative Test Method | Infor- mation Last Updated | ||||
|---|---|---|---|---|---|---|
| Name & Description | Validation Status | Regulatory Status | Effect or Potential Effect on Animal Use | |||
| Skin Sensitization | ||||||
Skin Sensitization
|
Classical Local Lymph Node Assay (LLNA) |
EU: Endorsed as valid by ECVAM (2000) US: Endorsed as valid by ICCVAM and recommended for use as a stand-alone substitute for the guinea pig sensitization test (1999) |
OECD: TG 429 (2002) International Standards Organization [ISO] 10993-10: Tests for Irritation and Sensitization (2002) EU: Method B.42 in Annex to 440/2008/EC (2004, 2008) US: EPA Health Effect Testing Guidelines on Skin Sensitization (2003) |
Reduction Refinement |
April 2009 | |
| Classical Local Lymph Node Assay (LLNA) (OECD TG 429) | rLLNA (Reduced Local Lymph Node Assay: Limit Dose Procedure) |
EU: Endorsed by ECVAM as a substitute method for the LLNA to distinguish between skin sensitizers and non-sensitizers when used as part of a tiered testing strategy (2007). US: When dose-response information is not required, ICCVAM recommends use of the LLNA limit dose procedure as for hazard identification to identify sensitizers and non-sensitizers. When dose-response information is required, ICCVAM recommended rLLNA be used as the initial testing procedure to identify sensitizers and non-sensitizers. |
No information |
Reduction
|
April 2009 | |
List of Abbreviations
© 2009 CCAC, All Rights Reserved

